Pancreatic Cancer Research

ResearcherJikei University School of MedicineActive in the last 2 years

Hironori Shiozaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5318-7591; OpenAlex author ID A5050641993. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.16968↗
  2. D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study. Co-author DOI 10.21873/anticanres.16150↗
  3. Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer durin… Co-author DOI 10.1007/s12032-021-01625-4↗
  4. Usefulness of the mesopancreas-first approach using isolating tape in conversion surgery for pancreatic cancer. Co-author DOI 10.1016/j.suronc.2022.101850↗
  5. Practical significance of pancreatectomy with lymphadenectomy around the superior mesenteric artery for pancreatic cancer: comparison of prognosis after adjust… Co-author DOI 10.1007/s00423-021-02166-0↗
  6. Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001767↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toru Ikegami · 5 shared papers, 2021–2024 · strength 0.85
  2. Yoshihiro Shirai · 4 shared papers, 2021–2024 · strength 0.63
  3. Ryoga Hamura · 4 shared papers, 2021–2024 · strength 0.63
  4. Shinji Onda · 4 shared papers, 2021–2024 · strength 0.60
  5. Kenei Furukawa · 4 shared papers, 2021–2024 · strength 0.60
  6. Takeshi Gocho · 4 shared papers, 2021–2023 · strength 0.57
  7. Kyohei Abe · 3 shared papers, 2022–2024 · strength 0.50
  8. Shuichi Fujioka · 2 shared papers, 2022–2023 · strength 0.38
  9. Masashi Tsunematsu · 2 shared papers, 2023–2024 · strength 0.35
  10. Koichiro Haruki · 2 shared papers, 2023–2024 · strength 0.35
  11. Taro Sakamoto · 2 shared papers, 2021–2023 · strength 0.29
  12. Tadashi Uwagawa · 2 shared papers, 2021–2022 · strength 0.28
  13. Michinori Matsumoto · 1 shared paper, 2024 · strength 0.19
  14. Yoshiaki Tanji · 1 shared paper, 2024 · strength 0.19
  15. Hiroaki Shiba · 1 shared paper, 2021 · strength 0.13
  16. Katsuhiko K. Yanaga · 1 shared paper, 2021 · strength 0.13
  17. Takashi Horiuchi · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.